Form 4: Health In Tech CFO Granted 80,000 Restricted Shares

Health In Tech's CFO, LinLin Qian, was granted 80,000 restricted Class A Common Stock shares, vesting upon key milestones of a new company initiative.

Summary

• LinLin Qian, Chief Financial Officer, Director, and 10% Owner of Health In Tech, Inc. (HIT), acquired 80,000 shares of Class A Common Stock on September 24, 2025.
• The acquired shares are restricted stock granted at a price of $0 under the Health in Tech Equity Incentive Plan.
• Vesting for these 80,000 restricted shares is structured in three equal one-third installments, each vesting monthly over a 12-month period.
• The vesting commencement dates are tied to specific milestones of a company 'Initiative': signing of a letter of intent/memorandum of understanding, entry into proof-of-concept/beta launch, and full commercial launch.
• Following this transaction, LinLin Qian beneficially owns 8,128,555 shares of Class A Common Stock directly.
• This total beneficial ownership includes 130,495 restricted shares (which encompasses the newly granted 80,000 shares) and 7,998,060 unrestricted Class A Common Stock.
• Excluded from this reported Class A beneficial ownership are 2,700,000 shares of Class B Common Stock and 711,510 options to purchase Class A Common Stock.

Sentiment

Score: 7

Explanation: The grant of restricted stock to a key executive, tied to the success of a new company initiative, is a positive signal for management alignment and commitment to future growth. It reinforces the company's strategy to incentivize performance for new ventures.

Positives

• The grant of restricted shares aligns the Chief Financial Officer's long-term incentives directly with the success and growth of a new company initiative, fostering commitment and performance.
• Equity-based compensation at a $0 acquisition price is a common method to attract and retain key executives, signaling confidence in the company's future value.

Negatives

• The vesting of the restricted shares is contingent upon the achievement of specific milestones for an 'Initiative,' which introduces a degree of uncertainty regarding the timing and ultimate realization of the equity for the executive.
• The shares are restricted, meaning they are not immediately liquid for the recipient.

Risks

• The successful execution and achievement of milestones for the 'Initiative' are critical for the vesting of the restricted shares, and failure to meet these could impact executive compensation and potentially company performance.
• Details about the 'Initiative' itself are not fully disclosed, which could represent an operational or strategic risk if the initiative faces unforeseen challenges.

Future Outlook

The future outlook for the granted shares is directly tied to the successful progression and commercialization of a new company 'Initiative,' with vesting milestones set at the signing of a letter of intent, proof-of-concept/beta launch, and full commercial launch.

Industry Context

The grant of restricted stock to a key executive is a standard practice in the technology and healthcare sectors for executive compensation, aiming to align management's interests with long-term shareholder value creation, particularly when tied to strategic project milestones.

Comparison to Industry Standards

• Equity incentive plans with performance-based or time-based vesting are a common component of executive compensation packages across industries, including healthcare technology.
• The structure of vesting tied to specific project milestones, such as proof-of-concept or commercial launch, is frequently observed in companies developing new products or services, similar to practices at innovative biotech or software firms.

Stakeholder Impact

• Shareholders: The grant aligns the CFO's financial interests with the company's long-term success, particularly for a new strategic initiative, potentially leading to enhanced shareholder value.
• Employees: May signal a focus on new projects and growth, potentially creating new opportunities or reinforcing strategic direction.

Next Steps

• Monitor the progress and public announcements regarding the 'Initiative' to which the restricted shares' vesting is tied.
• Observe future Form 4 filings for LinLin Qian to track vesting events or further changes in beneficial ownership.

Key Dates

Recommendation

This filing reports a routine executive compensation grant of restricted stock, which aligns management incentives with company performance, especially for a new initiative. While positive for corporate governance and long-term alignment, it does not present new financial data or strategic shifts that would warrant an immediate change in investment recommendation. It reinforces a 'hold' position, indicating continued monitoring of the company's strategic execution.

Keywords

Health In Tech, HIT, LinLin Qian, Form 4, Insider Transaction, Restricted Stock, Equity Incentive Plan, CFO, Director, 10% Owner, Executive Compensation